The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Basic and Clinical Pharmacology
Katzung, B. G. (1982) · Andalas University Repository (Andalas University) · Cited by 1,914
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Fleige, E., Quadir, M. A., & Haag, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.020 · Cited by 1,111
Multivalency as a Chemical Organization and Action Principle
Fasting, C., Schalley, C. A., Weber, M., Seitz, O., Hecht, S., Koksch, B., Dernedde, J., Graf, C., Knapp, E., & Haag, R. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201114 · Cited by 993
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
Transdermal drug delivery: overcoming the skin’s barrier function
Naik, A., Kalia, Y. N., & Guy, R. H. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00295-9 · Cited by 720
Biomedical applications of dendrimers: a tutorial
Mintzer, M. A., & Grinstaff, M. W. (2011) · Chem. Soc. Rev. · doi:10.1039/b901839p · Cited by 671
Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., & Hawkins, M. J. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 667
Kojima, C., Kono, K., Maruyama, K., & Takagishi, T. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000583 · Cited by 663
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Rapid translocation of nanoparticles from the lung airspaces to the body
Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler-Behnke, M., Frangioni, J. V., & Tsuda, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1696 · Cited by 648
Influence of particle size on regional lung deposition – What evidence is there?
Carvalho, T. C., Peters, J. I., & Williams III, R. O. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.040 · Cited by 614
Hong, S., Bielinska, A. U., Mecke, A., Keszler, B., Beals, J. L., Shi, X., Balogh, L., Orr, B. G., Baker, J. R., & Banaszak Holl, M. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049962b · Cited by 603
HPMA copolymers: Origins, early developments, present, and future☆
Kopeček, J., & Kopečková, P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.004 · Cited by 576
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Therapeutic and diagnostic applications of dendrimers for cancer treatment☆
WOLINSKY, J., & GRINSTAFF, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.012 · Cited by 540
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging
Tomalia, D. A., Reyna, L. A., & Svenson, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350061 · Cited by 496
Basic and Clinical Pharmacology
Holley, F. (1984) · Anesthesiology · doi:10.1097/00000542-198403000-00038 · Cited by 488
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Nanotechnological applications in medicine
Caruthers, S. D., Wickline, S. A., & Lanza, G. M. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.01.006 · Cited by 441
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Dendrimer-platinate: a novel approach to cancer chemotherapy.
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · PubMed · Cited by 417
Freitas, R. A. (2005) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2004.11.003 · Cited by 415
Dendrimer-platinate: a novel approach to cancer chemotherapy
Malik, N., Evagorou, E. G., & Duncan, R. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199909000-00010 · Cited by 402
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Design principles of chemical penetration enhancers for transdermal drug delivery
Karande, P., Jain, A., Ergun, K., Kispersky, V., & Mitragotri, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501176102 · Cited by 399
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin
Chauhan, A. S., Sridevi, S., Chalasani, K. B., Jain, A. K., Jain, S. K., Jain, N. K., & Diwan, P. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00200-1 · Cited by 344
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation
Shaunak, S., Thomas, S., Gianasi, E., Godwin, A., Jones, E., Teo, I., Mireskandari, K., Luthert, P., Duncan, R., Patterson, S., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt995 · Cited by 331
Singh, P., Gupta, U., Asthana, A., & Jain, N. K. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800125u · Cited by 329
McCarthy, T. D., Karellas, P., Henderson, S. A., Giannis, M., O'Keefe, D. F., Heery, G., Paull, J. R. A., Matthews, B. R., & Holan, G. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050023q · Cited by 314
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.002 · Cited by 314
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
Sadekar, S., & Ghandehari, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.010 · Cited by 311
Duan, X., & Sheardown, H. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.04.022 · Cited by 306
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
Hörl, W. H. (2010) · Pharmaceuticals · doi:10.3390/ph3072291 · Cited by 298
Nanoparticles made from novel starch derivatives for transdermal drug delivery
Santander-Ortega, M. J., Stauner, T., Loretz, B., Ortega-Vinuesa, J. L., Bastos-González, D., Wenz, G., Schaefer, U. F., & Lehr, C. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.012 · Cited by 295
Barth, R. F., Adams, D. M., Soloway, A. H., Alam, F., & Darby, M. V. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00025a008 · Cited by 285
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Chemical Penetration Enhancers for Transdermal Drug Delivery Systems
Pathan, I., & Setty, C. (2009) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v8i2.44527 · Cited by 270
D'Emanuele, A., Jevprasesphant, R., Penny, J., & Attwood, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.006 · Cited by 269
Gillies, E. R., Dy, E., Fréchet, J. M. J., & Szoka, F. C. (2005) · Molecular Pharmaceutics · doi:10.1021/mp049886u · Cited by 265
Nanoparticle Technology for Drug Delivery
(2006) · CRC Press eBooks · doi:10.1201/9780849374555 · Cited by 264
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Thomas, B. J., & Finnin, B. C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03180-0 · Cited by 245
Wiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234
Küchler, S., Radowski, M. R., Blaschke, T., Dathe, M., Plendl, J., Haag, R., Schäfer-Korting, M., & Kramer, K. D. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.019 · Cited by 233
Duncan, R., & Vicent, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.005 · Cited by 230
Yiyun, C., Na, M., Tongwen, X., Rongqiang, F., Xueyuan, W., Xiaomin, W., & Longping, W. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20745 · Cited by 225
Pulmonary delivery of therapeutic siRNA
Lam, J. K.-W., Liang, W., & Chan, H.-K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.006 · Cited by 216
Dendrimers as therapeutic agents: a systematic review
Gajbhiye, V., Palanirajan, V. K., Tekade, R. K., & Jain, N. K. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp/61.08.0002 · Cited by 210
Recent Advances in Ocular Drug Delivery Systems
Kuno, N., & Fujii, S. (2011) · Polymers · doi:10.3390/polym3010193 · Cited by 202
Nanocarriers in Ocular Drug Delivery: An Update Review
Wadhwa, S., Paliwal, R., Paliwal, S., & Vyas, S. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788923886 · Cited by 196
Wu, G., Barth, R. F., Yang, W., Chatterjee, M., Tjarks, W., Ciesielski, M. J., & Fenstermaker, R. A. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0341674 · Cited by 193
Iezzi, R., Guru, B. R., Glybina, I. V., Mishra, M. K., Kennedy, A., & Kannan, R. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.010 · Cited by 192
Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060367 · Cited by 190
Tardi, P., Boman, N., & Cullis, P. (1996) · Journal of Drug Targeting · doi:10.3109/10611869609015970 · Cited by 184
Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid
Wiwattanapatapee, R., Lomlim, L., & Saramunee, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00461-3 · Cited by 178
Designing dendrimers for ocular drug delivery
Spataro, G., Malecaze, F., Turrin, C.-O., Soler, V., Duhayon, C., Elena, P.-P., Majoral, J.-P., & Caminade, A.-M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.10.017 · Cited by 172
Self-citationBarnard, A., Posocco, P., Pricl, S., Calderon, M., Haag, R., Hwang, M. E., Shum, V. W. T., Pack, D. W., & Smith, D. K. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2070736 · Cited by 170
Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Jerger, K., Macaraeg, N., & Szoka, F. C. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9001206 · Cited by 168
Thompson, G. R., Cadena, J., & Patterson, T. F. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.001 · Cited by 165
Polymer Conjugates: Pharmacokinetic Considerations for Design and Development
Duncan, R., & Spreafico, F. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00004 · Cited by 164
Kihara, F., Arima, H., Tsutsumi, T., Hirayama, F., & Uekama, K. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025613a · Cited by 161
Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight Heparin
Bai, S., Thomas, C., & Ahsan, F. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20849 · Cited by 158
Yang, Y., Sunoqrot, S., Stowell, C., Ji, J., Lee, C.-W., Kim, J. W., Khan, S. A., & Hong, S. (2012) · Biomacromolecules · doi:10.1021/bm300545b · Cited by 158
Chauhan, A. S., Jain, N. K., Diwan, P. V., & Khopade, A. J. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010655 · Cited by 158
Transport of dendrimer nanocarriers through epithelial cells via the transcellular route
Jevprasesphant, R., Penny, J. I., Attwood, D., & D’Emanuele, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.022 · Cited by 156
Alternative Routes of Drug Administration—Advantages and Disadvantages (Subject Review)
(1997) · PEDIATRICS · doi:10.1542/peds.100.1.143 · Cited by 154
Bielinska, A. U., Yen, A., Wu, H. L., Zahos, K. M., Sun, R., Weiner, N. D., Baker, J. R., & Roessler, B. J. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00229-x · Cited by 151
Polymer Therapeutics for Cancer: Current Status and Future Challenges
Satchi‐Fainaro, R., Duncan, R., & Barnés, C. M. (2005) · Springer eBooks · doi:10.1007/12_024 · Cited by 146
Kaminskas, L. M., McLeod, V. M., Porter, C. J. H., & Boyd, B. J. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2005966 · Cited by 143
Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability
Jain, N. K., & Gupta, U. D. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.8.1035 · Cited by 142
Venuganti, V. V. K., & Perumal, O. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21603 · Cited by 142
Dufès, C., Keith, W. N., Bilsland, A. E., Proutski, I., Uchegbu, I. F., & Schätzlein, A. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4402 · Cited by 139
Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations
Wijagkanalan, W., Kawakami, S., & Hashida, M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0339-8 · Cited by 139
Kaminskas, L. M., Kelly, B. D., McLeod, V. M., Sberna, G., Owen, D. J., Boyd, B. J., & Porter, C. J. H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.005 · Cited by 137
Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates
Wada, K., Arima, H., Tsutsumi, T., Chihara, Y., Hattori, K., Hirayama, F., & Uekama, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.016 · Cited by 136
Dorsal root ganglia sensory neuronal cultures: a tool for drug discovery for peripheral neuropathies
Melli, G., & Höke, A. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903266829 · Cited by 133
Polyether based amphiphiles for delivery of active components
Gupta, S., Tyagi, R., Parmar, V. S., Sharma, S. K., & Haag, R. (2012) · Polymer · doi:10.1016/j.polymer.2012.04.047 · Cited by 132
Synthesis, Characterization, and Biological Evaluation of Integrin αvβ3-Targeted PAMAM Dendrimers
Boswell, C. A., Eck, P., Regino, C. A. S., Bernardo, M., Wong, K. J., Milenic, D. E., Choyke, P. L., & Brechbiel, M. W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800022a · Cited by 128
Intravascular and Endobronchial DNA Delivery to Murine Lung Tissue Using a Novel, Nonviral Vector
Kukowska‐Latallo, J. F., Chen, C., Raczka, E., Qunintana, A., Rymaszewski, M., & Baker, J. R. (2000) · Human Gene Therapy · doi:10.1089/10430340050057468 · Cited by 116
The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates
Gajbhiye, V., & Jain, N. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.04.057 · Cited by 115
Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry
Mignani, S. M., Kazzouli, S. E., Bousmina, M., & Majoral, J. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.03.003 · Cited by 114
Self-citationMan, N., Yiyun, C., Xu, T., Ding, Y., Xiaomin, W., Li, Z., Zhichao, C., Huang, G., Shi, Y., & Wen, L. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.01.001 · Cited by 113
Sato, N., Kobayashi, H., Saga, T., Nakamoto, Y., Ishimori, T., Togashi, K., Fujibayashi, Y., Konishi, J., & Brechbiel, M. W. (2001) · PubMed · Cited by 109
Oral uptake and translocation of a polylysine dendrimer with a lipid surface
Florence, A. T., Sakthivel, T., & Tóth, I. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00237-0 · Cited by 108
Design of stimuli-responsive dendrimers
Kojima, C. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903530651 · Cited by 105
Wang, Z., Itoh, Y., Hosaka, Y., Kobayashi, I., Nakano, Y., Maeda, I., Umeda, F., Yamakawa, J., Kawase, M., & Yag, K. (2003) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(03)80059-2 · Cited by 103
Potential Oral Delivery of 7-Ethyl-10-Hydroxy-Camptothecin (SN-38) using Poly(amidoamine) Dendrimers
Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9572-9 · Cited by 100
HPMA copolymer–cyclic RGD conjugates for tumor targeting☆☆☆
Pike, D. B., & Ghandehari, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.027 · Cited by 99
Marano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Tóth, I., Brankov, M., & Rakoczy, P. E. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.06.023 · Cited by 92
Yang, W., Barth, R. F., Adams, D. M., Ciesielski, M. J., Fenstermaker, R. A., Shukla, S., Tjarks, W., & Caligiuri, M. A. (2002) · PubMed · Cited by 91
Vincent, L., Varet, J., Pille, J., Bompais, H., Opolon, P., Maksimenko, A., Malvy, C., Mirshahi, M., Lu, H., Vannier, J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11105 · Cited by 88
Current oral and non-oral routes of antiepileptic drug delivery
Anderson, G. D., & Saneto, R. P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.017 · Cited by 88
Inapagolla, R., Guru, B. R., Kurtoglu, Y. E., Gao, X., Lieh-Lai, M. W., Bassett, D. J. P., & Kannan, R. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.030 · Cited by 85
Stimuli sensitive amphiphilic dendrimers
Ramireddy, R. R., Raghupathi, K. R., Torres, D. A., & Thayumanavan, S. (2012) · New Journal of Chemistry · doi:10.1039/c2nj20879b · Cited by 82
Self-immolative dendrimers: A distinctive approach to molecular amplification
Avital‐Shmilovici, M., & Shabat, D. (2010) · Soft Matter · doi:10.1039/b922341j · Cited by 81
Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers
Filipowicz-Rachwał, A., & Wołowiec, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.033 · Cited by 78
Jiang, Y., Tang, G., Zhang, L.-H., Kong, S.-Y., Zhu, S., & Pei, Y. (2010) · Journal of drug targeting · doi:10.3109/10611860903494203 · Cited by 72
Polyamidoamine Dendrimers Can Improve the Pulmonary Absorption of Insulin and Calcitonin in Rats
Dong, Z., Hamid, K. A., Gao, Y., Lin, Y., Katsumi, H., Sakane, T., & Yamamoto, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22428 · Cited by 72
HPMA copolymers: 30years of advances☆
Lammers, T., & Ulbrich, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.004 · Cited by 70
Dendrimer-mediated drug delivery to the skin
Sun, M., Fan, A., Wang, Z., & Zhao, Y. (2012) · Soft Matter · doi:10.1039/c2sm07280g · Cited by 70
Glycine-Terminated Dendritic Amphiphiles for Nonviral Gene Delivery
Malhotra, S., Bauer, H., Tschiche, A., Staedtler, A. M., Mohr, A., Calderón, M., Parmar, V. S., Hoeke, L., Sharbati, S., Einspanier, R., et al. (2012) · Biomacromolecules · doi:10.1021/bm300892v · Cited by 70
Transdermal delivery of drugs for the treatment of bone diseases
Ramachandran, C., & Fleisher, D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00062-4 · Cited by 68
Pre-clinical and behavioural toxicity profile of PAMAM dendrimers in mice
Chauhan, A. S., Jain, N. K., & Diwan, P. V. (2009) · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rspa.2009.0448 · Cited by 62
Lactoferrin-Conjugated Dendritic Nanoconstructs for Lung Targeting of Methotrexate
Kurmi, B. D., Gajbhiye, V., Kayat, J., & Jain, N. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22469 · Cited by 61
Dendrimer therapeutics: covalent and ionic attachments
Kazzouli, S. E., Mignani, S. M., Bousmina, M., & Majoral, J. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20459a · Cited by 61
Self-citationDendrimer grafts for delivery of 5-fluorouracil.
Pk, T., Khopade, A. J., Nagaich, S., Shrivastava, S. K., Jain, S., & Nk, J. (2002) · PubMed · Cited by 61
Menjoge, A. R., Navath, R. S., Asad, A., Kannan, S., Kim, C. J., Romero, R. J., & Kannan, R. M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.075 · Cited by 59
Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy
Grobmyer, S. R., Singh, Hahn, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28357 · Cited by 57
DENDRIMER: A NOVEL DRUG DELIVERY SYSTEM
Mishra, I. (2011) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v1i2.46 · Cited by 54
Illum, L. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00260-0 · Cited by 52
Wang, Z., Itoh, Y., Hosaka, Y., Kobayashi, I., Nakano, Y., Maeda, I., Umeda, F., Yamakawa, J., Nishimine, M., Suenobu, T., et al. (2003) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(04)70146-2 · Cited by 51
Investigation of a novel dendritic derivative of 5-aminolaevulinic acid for photodynamic therapy
Venosa, G. M. D., Casas, A. G., Battah, S., Dobbin, P. S., Fukuda, H., MacRobert, A. J., & Batlle, A. M. D. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.001 · Cited by 50
Huber, V. C., Mondal, T. K., Factor, S. A., Seegal, R. F., & Lawrence, D. A. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-1 · Cited by 48
Borowska, K., Laskowska, B., Magoń, A., Myśliwiec, B., Pyda, M., & Wołowiec, S. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.019 · Cited by 47
Targeting approaches to oral drug delivery
Lambkin, I., & Pinilla, C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.67 · Cited by 44
Beyond oncology — Application of HPMA copolymers in non-cancerous diseases☆
Liu, X.-M., Miller, S. C., & Wang, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.006 · Cited by 41
Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration
Sakthivel, T., Tóth, I., & Florence, A. T. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00043-5 · Cited by 39
Floyd, W. C., Datta, G. K., Imamura, S., Ferguson, H. M., Jerger, K., Patterson, A. W., Fox, M. E., Szoka, F. C., Fréchet, J. M. J., & Ellman, J. A. (2010) · ChemMedChem · doi:10.1002/cmdc.201000377 · Cited by 34
Nano-vectors for the ocular delivery of nucleic acid-based therapeutics
Khar, R. K., Warsi, M. H., Akhter, S., Ahmad, F., Jain, G. K., Mallick, N., & Pathan, S. (2010) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.84575 · Cited by 26
Recent Advances in the Field of Nanometric Drug Carriers
Ogier, J. R., Arnauld, T., & Doris, E. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.48 · Cited by 26
Current Trends of Nanotechnology for Cancer Therapy
Anajwala, C. C., Jani, G. K., & Vijayendra Swamy, S. M. (2010) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2010.3.3.2 · Cited by 26
Seabrook, T. J., Jiang, L., Thomas, K., & Lemere, C. A. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-14 · Cited by 23
van Haandel, L., & Stobaugh, J. F. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3716-6 · Cited by 23
Nanoparticles for Ocular Drug Delivery
Amrite, A. C., & Kompella, U. B. (2006) · doi:10.1201/9780849374555-13 · Cited by 14
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Dendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Nanoparticles and nanofibers for topical drug delivery
Goyal, R., Macri, L. K., Kaplan, H. M., & Kohn, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.049 · Cited by 590
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Metadata
- Authors
- Mignani, S., El Kazzouli, S., Bousmina, M., & Majoral, J.-P.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 65
- Issue
- 10
- Pages
- 1316-1330
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2023959068
- Cited by
- 335
- References
- 136
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.